Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Holdings
Ownership



Sanofi (SNY)

DateNameSymbolTypeSecuritySharesPriceValueOwnershipReported
09/14/2021Translate Bio, Inc.TBIOPurchaseCommon Stock, par value $0.001 per share51.5M$38.00$1955.8M 09/14/2021
09/14/2021Translate Bio, Inc.TBIOPurchaseCommon Stock, par value $0.001 per share20.5M$38.00$779.6M 09/14/2021
08/02/2021Icosavax, Inc.ICVXConversionCommon Stock (par value, $0.0001)3.1M$0.00$0Through its wholly-owned subsidiary, Aventis Inc.08/02/2021
08/02/2021Icosavax, Inc.ICVXPurchaseCommon Stock (par value, $0.0001)66.7k$15.00$1MThrough its wholly-owned subsidiary, Aventis Inc.08/02/2021
08/02/2021Icosavax, Inc.ICVXConversionSeries A-1 Preferred Stock (par value, $0.0001)12.5M$0.00$0Through its wholly-owned subsidiary, Aventis Inc08/02/2021
08/02/2021Icosavax, Inc.ICVXConversionSeries B-1 Preferred Stock (par value, $0.0001)354.4k$0.00$0Through its wholly-owned subsidiary, Aventis Inc08/02/2021
07/28/2020Inozyme Pharma, Inc.INZYConversionCommon Stock (par value $0.0001)438.9k$0.00$0Through its wholly-owned subsidiary, Aventis Inc.07/28/2020
07/28/2020Inozyme Pharma, Inc.INZYPurchaseCommon Stock (par value $0.0001)81.2k$16.00$1.3MThrough its wholly-owned subsidiary, Aventis Inc.07/28/2020
07/28/2020Inozyme Pharma, Inc.INZYConversionSeries A Convertible Preferred Stock (par value, $0.0001)3.3M$0.00$0Through its wholly-owned subsidiary, Aventis Inc.07/28/2020
06/09/2020REGENERON PHARMACEUTICALS, INC.REGNSaleCommon Stock120.2k$597.48$71.8MSee note06/09/2020
05/29/2020REGENERON PHARMACEUTICALS, INC.REGNSaleCommon Stock20.4M$509.85$10412.1M 05/29/2020
05/29/2020REGENERON PHARMACEUTICALS, INC.REGNSaleCommon Stock2.4M$509.85$1223.4MSee note05/29/2020
03/09/2020REGENERON PHARMACEUTICALS, INC.REGNSaleCommon Stock128.9k$489.65$63.1M 03/09/2020
09/10/2019REGENERON PHARMACEUTICALS, INC.REGNSaleCommon Stock172.9k$281.15$48.6M 09/10/2019
07/22/2019Fulcrum Therapeutics, Inc.FULCConversionCommon Stock (par value $0.001)464.3k$0.00$0Through its wholly-owned subsidiary, Aventis Inc.07/22/2019
07/22/2019Fulcrum Therapeutics, Inc.FULCPurchaseCommon Stock (par value $0.001)93.8k$16.00$1.5MThrough its wholly-owned subsidiary, Aventis Inc.07/22/2019
07/22/2019Fulcrum Therapeutics, Inc.FULCConversionSeries B Preferred Stock (par value $0.001)3.2M$0.00$0Through its wholly-owned subsidiary, Aventis Inc.07/22/2019
03/08/2019REGENERON PHARMACEUTICALS, INC.REGNSaleCommon Stock131.1k$412.17$54M 03/08/2019
02/13/2019MyoKardia, Inc.MYOKSaleCommon Stock (par value $0.0001)4.2M$37.66$157MVia wholly-owned subsidiary, Aventis Inc.02/13/2019
09/06/2018REGENERON PHARMACEUTICALS, INC.REGNSaleCommon Stock104.6k$406.68$42.5MSee note09/06/2018
06/08/2018REGENERON PHARMACEUTICALS, INC.REGNSaleCommon Stock121.6k$309.31$37.6MSee note06/08/2018
05/25/2018MyoKardia, Inc.MYOKPurchaseCommon stock Par value per share $ 0.0001150k$49.00$7.4MVia wholly owned subsidiary Aventis Inc.05/25/2018
08/25/2017REGENERON PHARMACEUTICALS, INC.REGNPurchaseCommon Stock3.7k$479.19$1.8MSee note08/25/2017
08/25/2017REGENERON PHARMACEUTICALS, INC.REGNPurchaseCommon Stock28.6k$479.93$13.7MSee note08/25/2017
08/25/2017REGENERON PHARMACEUTICALS, INC.REGNPurchaseCommon Stock21.4k$480.75$10.3MSee note08/25/2017
08/25/2017REGENERON PHARMACEUTICALS, INC.REGNPurchaseCommon Stock1.3k$481.63$627.1kSee note08/25/2017
08/25/2017REGENERON PHARMACEUTICALS, INC.REGNPurchaseCommon Stock4.5k$482.87$2.2MSee note08/25/2017
08/25/2017REGENERON PHARMACEUTICALS, INC.REGNPurchaseCommon Stock2k$484.21$968.4kSee note08/25/2017
08/25/2017REGENERON PHARMACEUTICALS, INC.REGNPurchaseCommon Stock5.7k$485.28$2.8MSee note08/25/2017
08/25/2017REGENERON PHARMACEUTICALS, INC.REGNPurchaseCommon Stock2.7k$485.99$1.3MSee note08/25/2017
08/25/2017REGENERON PHARMACEUTICALS, INC.REGNPurchaseCommon Stock2.6k$487.01$1.2MSee note08/25/2017
08/24/2017REGENERON PHARMACEUTICALS, INC.REGNPurchaseCommon Stock2.6k$474.86$1.3MSee note08/23/2017
08/24/2017REGENERON PHARMACEUTICALS, INC.REGNPurchaseCommon Stock5.1k$475.93$2.4MSee note08/23/2017
08/24/2017REGENERON PHARMACEUTICALS, INC.REGNPurchaseCommon Stock10.9k$477.42$5.2MSee note08/23/2017
08/24/2017REGENERON PHARMACEUTICALS, INC.REGNPurchaseCommon Stock3.3k$478.12$1.6MSee note08/23/2017
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy